Trials / Conditions / Renal Cancer Metastatic
Renal Cancer Metastatic
6 registered clinical trials studyying Renal Cancer Metastatic — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer NCT05285579 | Assistance Publique - Hôpitaux de Paris | — |
| Active Not Recruiting | CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy NCT05215470 | Hospital das Clínicas de Ribeirão Preto | Phase 2 |
| Recruiting | SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC NCT06889649 | Peking University First Hospital | Phase 2 |
| Unknown | BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer) NCT03628859 | Centre Leon Berard | — |
| Unknown | A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma NCT03736330 | Sun Yat-sen University | Phase 2 |
| Completed | Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcin NCT03469713 | Gruppo Oncologico Italiano di Ricerca Clinica | Phase 2 |